Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Citing this Article

Right click to copy or hit: ctrl+c (cmd+c on mac)

Published on 21.07.17 in Vol 19, No 7 (2017): July

This paper is in the following e-collection/theme issue:

Works citing "Adherence to Web-Based Self-Assessments in Long-Term Direct-to-Patient Research: Two-Year Study of Multiple Sclerosis Patients"

According to Crossref, the following articles are citing this article (DOI 10.2196/jmir.6729):

(note that this is only a small subset of citations)

  1. Jongen PJ, van Mastrigt GA, Heerings M, Visser LH, Ruimschotel RP, Hussaarts A, Duyverman L, Valkenburg-Vissers J, Cornelissen J, Bos M, van Droffelaar M, Donders R, Friede T. Effect of an intensive 3-day social cognitive treatment (can do treatment) on control self-efficacy in patients with relapsing remitting multiple sclerosis and low disability: A single-centre randomized controlled trial. PLOS ONE 2019;14(10):e0223482
    CrossRef
  2. Jongen PJ, ter Veen G, Lemmens W, Donders R, van Noort E, Zeinstra E. The Interactive Web-Based Program MSmonitor for Self-Management and Multidisciplinary Care in Persons With Multiple Sclerosis: Quasi-Experimental Study of Short-Term Effects on Patient Empowerment. Journal of Medical Internet Research 2020;22(3):e14297
    CrossRef
  3. Nowell WB, Merkel PA, McBurney RN, Young K, Venkatachalam S, Shaw DG, Dobes A, Cerciello E, Kolaczkowski L, Curtis JR, Kappelman MD. Patient-Powered Research Networks of the Autoimmune Research Collaborative: Rationale, Capacity, and Future Directions. The Patient - Patient-Centered Outcomes Research 2021;14(6):699
    CrossRef
  4. De Angelis M, Lavorgna L, Carotenuto A, Petruzzo M, Lanzillo R, Brescia Morra V, Moccia M. Digital Technology in Clinical Trials for Multiple Sclerosis: Systematic Review. Journal of Clinical Medicine 2021;10(11):2328
    CrossRef
  5. Visser L, Huls S, Uyl-de Groot C, de Bekker-Grob E, Redekop W. An implantable device to treat multiple sclerosis: A discrete choice experiment on patient preferences in three European countries. Journal of the Neurological Sciences 2021;428:117587
    CrossRef
  6. Altmann P, Ponleitner M, Monschein T, Krajnc N, Zulehner G, Zrzavy T, Leutmezer F, Rommer PS, Kornek B, Berger T, Bsteh G. Feasibility of a smartphone app to monitor patient reported outcomes in multiple sclerosis: The haMSter interventional trial. DIGITAL HEALTH 2022;8:205520762211353
    CrossRef
  7. Jonsdottir J, Santoyo-Medina C, Kahraman T, Kalron A, Rasova K, Moumdjian L, Coote S, Tacchino A, Grange E, Smedal T, Arntzen EC, Learmonth Y, Pedulla L, Quinn G, Kos D. Changes in physiotherapy services and use of technology for people with multiple sclerosis during the COVID-19 pandemic. Multiple Sclerosis and Related Disorders 2023;71:104520
    CrossRef
  8. Rothstein MA, Zawati MH, Beskow LM, Brelsford KM, Brothers KB, Hammack-Aviran CM, Hazel JW, Joly Y, Lang M, Patrinos D, Saltzman A, Knoppers BM. Legal and Ethical Challenges of International Direct-to-Participant Genomic Research: Conclusions and Recommendations. Journal of Law, Medicine & Ethics 2019;47(4):705
    CrossRef
  9. Reece JC, Yu M, Bevens W, Simpson-Yap S, Jelinek G, Jelinek P, Davenport R, Nag N, Gray K, Neate S. Study protocol for an online lifestyle modification education course for people living with multiple sclerosis: the multiple sclerosis online course (MSOC). BMC Neurology 2023;23(1)
    CrossRef